Clinical trial
Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)
NCT06950190 is registered in ClinicalTrials.gov with Ellis Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)
- Lead sponsor
- Ellis Medicine
- Phase
- Phase 3
- Overall status
- Enrolling by invitation
- Start date
- June 9, 2025
- Completion date
- February 20, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.